TB-500 is the name commonly used for a synthetic peptide corresponding to the active region of Thymosin Beta-4, a naturally occurring protein involved in cell structure and motility. It is frequently discussed alongside BPC-157 in tissue-repair research literature, though its proposed mechanism of action is distinct.
Thymosin Beta-4 and Actin Regulation
Thymosin Beta-4 is one of the most abundant intracellular actin-binding proteins in many cell types. Actin is a core structural protein involved in cell shape, movement and division, and Thymosin Beta-4’s role in sequestering and regulating available actin monomers is central to why it, and the TB-500 fragment derived from its active region, are studied in cell-motility research.
Research on Cell Migration
Because actin dynamics underlie cell migration, a significant portion of the TB-500 literature examines its effects on the movement of cell types relevant to wound healing — including endothelial cells, keratinocytes and various progenitor cell populations — in cell-culture and animal models. This research frames TB-500 as a tool for probing cytoskeletal-dependent repair processes rather than as a therapy.
Angiogenesis Research
Similar to BPC-157, TB-500 has been studied for its association with angiogenic signalling in preclinical wound and tissue-injury models, with research examining blood vessel formation as one component of the broader tissue-repair process being modelled.
Research Combining BPC-157 and TB-500
A portion of the literature and a number of research-compound catalogues discuss BPC-157 and TB-500 together, on the basis that their proposed mechanisms — growth-factor and angiogenesis pathways for BPC-157, actin and cell-motility regulation for TB-500 — are viewed by some researchers as complementary within tissue-repair models. Any such combination in a research protocol should be designed and evaluated independently against the relevant literature for the specific model in use.
Handling and Documentation
TB-500 is supplied as a lyophilized peptide and follows the general storage and handling practices described in our lyophilized-compound handling overview: freezer storage prior to use, gradual warming before opening, and refrigerated, prompt use once reconstituted.
Research Use Only. This overview describes preclinical research themes associated with TB-500 for general scientific education. It does not describe or endorse any human or veterinary use, dosing or treatment.